IBEC researchers develop a three-dimensional model of muscle tissue using bioprinting and tissue bioengineering techniques that allow reproducing their strength, contraction and aging profiles. The ne...
Read more
GENESIS Biomed, a consulting company specialized in R + D projects in biomedicine, has recently established its Business Advisory Board, a multidisciplinary panel of experts, KOL in their respe...
Read more
A novel computer-guided design tool predicts combinations of transcription factors for more effective engineering of cell types with potential use in cell therapies and tissue modeling.
Read more
Minoryx Therapeutics, a Phase 3 clinical stage biotech company focused on the development of differentiating treatment options in orphan central nervous system (CNS) disorders, today announces that th...
Read more
The Barcelona Science Park (PCB), a Spain's leading scientific, technological and business innovation hub in the life sciences field, aims to embark on a new phase of growth, offering more than 1,200 ...
Read more
Researchers at the Institute for Bioengineering of Catalonia (IBEC) and the Catalan Institute of Nanoscience and Nanotechnology (ICN2) have developed a new type of encapsulated enzyme nanomotors.
Read more
Researchers at IRB Barcelona’s Cellular Plasticity and Disease Laboratory propose a more efficient way to limit cell plasticity without causing cell damage. The new method sheds light on processe...
Read more
Esteve and Leitat, CataloniaBio & HealthTech members, have signed a strategic alliance to create a business incubator specialising in biomedicine, that will be headquartered in the facilities that wer...
Read more
One of the basic processes of nature is the decomposition of organic matter, which requires the degradation of complex carbohydrate structures. To do so, it is necessary to break the long chains of...
Read more
The IrsiCaixa AIDS Research Institute celebrates its 25th anniversary as an international center of reference in the field of HIV and infectious diseases. The research at IrsiCaixa is now expanding to...
Read more
In June 2017, researchers from the IIB-Sant Pau, the Institute of Biotechnology and Biomedicine at the UAB and the CIBER-BBN, created a spin-off, Nanoligent, with the goal of developing the first drug...
Read more
GENESIS Ventures has presented today, a new investment fund located in Barcelona and made up of various family offices that are looking to invest in research and business projects in the very early st...
Read more
Un equipo de investigadores de la Universidad Juli...
A new technique allows the design of solid materia...
El estudio realizado sobre una muestra significati...
En nuestro post hablamos sobre este interesante tipo de célula del...
In crisis, the nucleus calls antioxidant enzymes to the rescue. The nu...
